OA11243A - Solubilized sertraline compositions - Google Patents

Solubilized sertraline compositions Download PDF

Info

Publication number
OA11243A
OA11243A OA9900301A OA9900301A OA11243A OA 11243 A OA11243 A OA 11243A OA 9900301 A OA9900301 A OA 9900301A OA 9900301 A OA9900301 A OA 9900301A OA 11243 A OA11243 A OA 11243A
Authority
OA
OAPI
Prior art keywords
composition
matter
agent
sertraline
acid
Prior art date
Application number
OA9900301A
Other languages
English (en)
Inventor
Dwayne Thomas Friesen
Ravi Mysore Shanker Sco Herbig
James Blair West
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=OA11243(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of OA11243A publication Critical patent/OA11243A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
OA9900301A 1997-07-01 1999-12-21 Solubilized sertraline compositions OA11243A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5141397P 1997-07-01 1997-07-01

Publications (1)

Publication Number Publication Date
OA11243A true OA11243A (en) 2003-07-24

Family

ID=21971159

Family Applications (1)

Application Number Title Priority Date Filing Date
OA9900301A OA11243A (en) 1997-07-01 1999-12-21 Solubilized sertraline compositions

Country Status (34)

Country Link
EP (1) EP0999829A1 (tr)
JP (1) JP2000514100A (tr)
KR (1) KR100366373B1 (tr)
CN (1) CN1261794A (tr)
AP (1) AP1192A (tr)
AR (3) AR015917A1 (tr)
AU (1) AU742535B2 (tr)
BG (1) BG103918A (tr)
BR (1) BR9810739A (tr)
CA (1) CA2290974C (tr)
CO (1) CO4940495A1 (tr)
DZ (1) DZ2548A1 (tr)
EA (1) EA002481B1 (tr)
HN (1) HN1998000102A (tr)
HR (1) HRP980377A2 (tr)
HU (1) HUP0002236A3 (tr)
ID (1) ID23429A (tr)
IL (1) IL133076A (tr)
IS (1) IS5260A (tr)
MA (1) MA24587A1 (tr)
NO (1) NO996520L (tr)
OA (1) OA11243A (tr)
PA (1) PA8454301A1 (tr)
PE (1) PE97199A1 (tr)
PL (1) PL337804A1 (tr)
SK (1) SK181099A3 (tr)
TN (1) TNSN98124A1 (tr)
TR (1) TR199903297T2 (tr)
TW (1) TW550087B (tr)
UA (1) UA67741C2 (tr)
UY (1) UY25071A1 (tr)
WO (1) WO1999001120A1 (tr)
YU (1) YU68299A (tr)
ZA (1) ZA985708B (tr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1712222A3 (en) 1999-12-23 2012-06-20 Pfizer Products Inc. Pharmaceutical compositions providing enhanced drug concentrations
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
BR0113626A (pt) 2000-08-30 2003-06-17 Pfizer Prod Inc Formulações de liberação sustentada para secretores de hormÈnio do crescimento
US20040191207A1 (en) * 2003-03-31 2004-09-30 Lipari John M. Alpha-hydroxy acid ester drug delivery compositions and methods of use
EP2117652B1 (en) * 2007-03-12 2013-09-25 DSM IP Assets B.V. Cosmetic compositions
US20120289517A1 (en) * 2009-12-29 2012-11-15 Kowa Co., Ltd. Solid pharmaceutical composition for oral administration
US20130035344A1 (en) * 2009-12-29 2013-02-07 Kowa Co., Ltd. Pharmaceutical composition for oral administration
CN109908354A (zh) * 2017-12-12 2019-06-21 万特制药(海南)有限公司 盐酸舍曲林口服浓缩液及其制备工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
DE69004529T2 (de) * 1989-08-30 1994-02-24 Pfizer Verwendung von Sertralin zur Behandlung von Abhängigkeiten von chemischen Stoffen.
ZA97976B (en) * 1996-04-05 1997-08-18 Alza Corp Uniform drug delivery theraphy.

Also Published As

Publication number Publication date
EA199900962A1 (ru) 2000-08-28
YU68299A (sh) 2002-06-19
AR015917A1 (es) 2001-05-30
PE97199A1 (es) 1999-10-05
HUP0002236A2 (hu) 2003-08-28
SK181099A3 (en) 2000-07-11
TW550087B (en) 2003-09-01
CA2290974A1 (en) 1999-01-14
AP9801280A0 (en) 1998-06-30
AU7544898A (en) 1999-01-25
BG103918A (en) 2000-07-31
CA2290974C (en) 2004-04-27
CN1261794A (zh) 2000-08-02
TR199903297T2 (tr) 2000-07-21
CO4940495A1 (es) 2000-07-24
KR20010013365A (ko) 2001-02-26
AU742535B2 (en) 2002-01-03
NO996520D0 (no) 1999-12-28
IL133076A (en) 2003-12-10
DZ2548A1 (fr) 2003-02-08
HRP980377A2 (en) 1999-04-30
AP1192A (en) 2003-07-23
EP0999829A1 (en) 2000-05-17
KR100366373B1 (ko) 2003-01-14
UY25071A1 (es) 2000-12-29
PL337804A1 (en) 2000-09-11
ID23429A (id) 2000-04-20
IL133076A0 (en) 2001-03-19
HUP0002236A3 (en) 2003-12-29
UA67741C2 (uk) 2004-07-15
AR040279A2 (es) 2005-03-23
MA24587A1 (fr) 1998-12-31
WO1999001120A1 (en) 1999-01-14
PA8454301A1 (es) 2000-09-29
HN1998000102A (es) 1999-01-08
JP2000514100A (ja) 2000-10-24
NO996520L (no) 2000-02-29
IS5260A (is) 1999-11-19
TNSN98124A1 (fr) 2005-03-15
AR040280A2 (es) 2005-03-23
BR9810739A (pt) 2000-09-12
EA002481B1 (ru) 2002-06-27
ZA985708B (en) 2000-01-10

Similar Documents

Publication Publication Date Title
CA1208559A (en) Pharmaceutical mixture
ES2341510T3 (es) Microemulsiones como formas farmaceuticas solidas para la administracion oral.
PT1492511E (pt) Formulação farmacêutica oral na forma de suspensão aquosa de microcápsulas para libertação modificada de princípio(s) activo(s)
US20070065513A1 (en) Stable lansoprazole formulation
PT1542658E (pt) Composições farmacêuticas que compreendem um analgésico opióide
BRPI0913822B1 (pt) forma farmacêutica oral de liberação controlada para evitar liberação imediata na presença de álcool, e uso da forma farmacêutica
PT1492531E (pt) Formulação farmacêutica oral sob a forma de suspensão aquosa de microcápsulas que permite a libertação modificada de amoxicilina
US11504345B2 (en) Extended release liquid compositions of metformin
ES2852899T3 (es) Formulaciones estabilizadas de molindona
RU2237480C2 (ru) Непосредственно прессуемая матрица для регулируемого высвобождения однократных ежедневных доз кларитромицина
US10258583B2 (en) Extended release liquid compositions of guanfacine
OA11243A (en) Solubilized sertraline compositions
WO2017182852A1 (en) Extended release liquid compositions of guanfacine
PT1618873E (pt) Grânulos para libertação controlada de tamsulosina, que contém alginato.
JP2005500307A (ja) プラバスタチンを含む安定な徐放性薬剤組成物
US20040208926A1 (en) Solubilized sertraline compositions
NZ501250A (en) Solubilized sertraline compositions
ES2896150T3 (es) Composiciones líquidas de liberación prolongada de guaifenesina
CZ464199A3 (cs) Solubilizované sertralinové kompozice
JPH111427A (ja) ソフトカプセル用基剤
MXPA99012101A (en) Solubilized sertraline compositions
AU2922800A (en) Pharmaceutical compositions for oral administration comprising a benzamide and at least an absorption promoter
JP2004518679A (ja) リポイドビヒクルに分散させたサムパトリラートを含む薬学的組成物
EP3445350A1 (en) Extended release liquid compositions of guanfacine
BR122013000700B1 (pt) "suspension microcapsules in a net stage aquasa"